Drugmaker Mundipharma International Ltd,owned by the billionaire American Sackler family, has kicked off the sale of its China unit in a deal that could fetch more than $1 billion, people familiar with the situation told Reuters.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com